Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead
Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
We love to hear from our listeners. Send us a message.
This week's special holiday episode of the Business of Biotech brings seven chief editors from the Life Science Connect family together to talk about the life sciences industry topics, trips, and reporting that mattered most in 2025, and what each editor has planned for 2026. From the RNA, cell, and gene therapy space to small molecule manufacturing, bioprocessing, drug discovery, and outsourcing, the editors weigh in on key industry trends, new developments, and policy surprises from their respective coverage areas. Topics include biotech funding dynamics, FDA leadership, China's growing role, favorite holiday movies, and much, much more. Special thanks to Tyler Menichiello and the Better Biopharma podcast for hosting this roundtable discussion. Happy New Year!
Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com
Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/
We love to hear from our listeners. Send us a message.
buzzsprout.comBusiness of Biotech
lifescienceleader.comBusiness of Biotech newsletter
www9.lifescienceleader.comhttps://www.linkedin.com/in/bencomer/
linkedin.com
- 0:00Two Shows, One Special Roundtable
- 0:54Meet The Editors At The Table
- 2:582025 vs. Expectations: Funding Reality
- 4:51Advanced Therapies: Risk Aversion And Scale
- 6:51RNA’s Crosswinds: Politics, Deals, Uncertainty
- 9:34Outsourcing Resilience And Tariff Workarounds
- 11:35Manufacturing Surge And Facility Investments
- 12:46Biggest Surprises: FDA Turnover And Morale
- 16:11Guidance Shifts And N-of-One Milestones
- 19:22Defining 2025: AI, NAMS, And In Vivo
- 23:08China’s Rising Biotech Influence
- 24:36Personal Highs: Travel, Panels, New Shows
- 28:01What We’re Building In 2026
- 32:39What To Watch: Policy, Jobs, Data Sharing
- 36:15Commercial Currents: GLP-1 And Coverage
- 39:20RNA Trials: Limits, Promise, And Competition
- 43:17Bioeconomy And Outsourcing’s Stress Test
- 46:03How To Better Biopharma: Our Playbook
- 52:57Holiday Sign-Off And Favorite Movies